Logo (EUIPO, 01/06/2023)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark was filed as Figurative mark on 01/06/2023 at the European Union Intellectual Property Office.
It was registered as a trademark on 05/18/2023.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#One circle #Other geometrical solids #Letters or numerals forming some other geometrical figure #One letter #Letter 'C'
| Trademark form | Figurative mark |
| File reference | 018818757 |
| Application date | January 6, 2023 |
| Publication date | February 8, 2023 |
| Entry date | May 18, 2023 |
| Expiration date | January 6, 2033 |
Trademark owner
350 Oyster Point Boulevard
94080 South San Francisco
US
94080 South San Francisco
US
goods and services
5
Human pharmaceuticals for the treatment of cardiovascular diseases, pulmonary diseases, pulmonary conditions, bronchoconstrictive diseases, bronchoconstrictive conditions, diseases and conditions associated with cardiac muscle dysfunction, cardiac muscle wasting, cardiac muscle atrophy, cardiac muscle weakness, infectious diseases, neurological diseases and conditions, neuromuscular diseases and conditions, musculoskeletal disorders, and diseases and conditions associated with skeletal muscle dysfunction; human pharmaceuticals for the treatment of skeletal muscle wasting, skeletal muscle atrophy, skeletal muscle weakness, metabolic diseases and disorders, diabetes, hypertension, vascular diseases, and diseases and conditions associated with dysfunction of non-muscle myosin
42
Consultation and collaboration relating to drug discovery and patient diagnosis; research in the field of cellular assay screening and pharmaceutical discovery and development; information services relating to the aforesaid
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| February 12, 2024 | Change Representative, Published | ||
| May 26, 2023 | Change Representative, Published |
ID: 11018818757